We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

23 hedge funds and large institutions have $4.72M invested in Microbot Medical in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $3.89M → $4.72M (+$831K)

0.14% less ownership

Funds ownership: 9.76% → 9.62% (-0.14%)

21% less funds holding

Funds holding: 29 → 23 (-6)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
23
Holders Change
-6
Holders Change %
-20.69%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.3K
2
Wells Fargo
Wells Fargo
California
+$6.77K
3
JP Morgan Chase
JP Morgan Chase
New York
+$27
4
BCM
Bourgeon Capital Management
Connecticut
+$14

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$538K
2
Citadel Advisors
Citadel Advisors
Florida
-$103K
3
Morgan Stanley
Morgan Stanley
New York
-$93.8K
4
UBS Group
UBS Group
Switzerland
-$20.9K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$20K

MBOT Hedge Fund Activity: Q2 2020 in Review

23 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2020, worth a combined $4.72M — up 21% from $3.89M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MBOT and 2 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was BlackRock, adding an estimated $12.3K. The largest seller was Renaissance Technologies, cutting an estimated $538K.

  • 23 institutional investors held Microbot Medical (MBOT) as of Q2 2020, down from 29 in Q1 2020.
  • Funds reported $4.72M of Microbot Medical stock for Q2 2020, up 21% quarter-over-quarter.
  • 2 funds opened new Microbot Medical positions in Q2 2020 and 8 closed out, a net change of -6 holders.
  • The largest Microbot Medical buyer in Q2 2020 was BlackRock, an estimated $12.3K added.
  • The largest Microbot Medical seller in Q2 2020 was Renaissance Technologies, an estimated $538K sold.

Based on aggregated 13F filings for Q2 2020.